Edoardo Lanino
Edoardo Lanino
Istituto G. Gaslini Genova, UOSD Trapianto Midollo
Email verificata su gaslini.org
TitoloCitata daAnno
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
K Le Blanc, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, ...
The Lancet 371 (9624), 1579-1586, 2008
23922008
Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the …
D Pende, GM Spaggiari, S Marcenaro, S Martini, P Rivera, A Capobianco, ...
Blood 105 (5), 2066-2073, 2005
3442005
Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host …
K Le Blanc, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, ...
Lancet 371 (9624), 1579-1586, 2008
2912008
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial
F Locatelli, P Nöllke, M Zecca, E Korthof, E Lanino, C Peters, A Pession, ...
Blood 105 (1), 410-419, 2005
2732005
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1–poliovirus receptor interaction
R Castriconi, A Dondero, MV Corrias, E Lanino, D Pende, L Moretta, ...
Cancer research 64 (24), 9180-9184, 2004
2182004
The mutational spectrum of human malignant autosomal recessive osteopetrosis
C Sobacchi, A Frattini, P Orchard, O Porras, I Tezcan, M Andolina, ...
Human molecular genetics 10 (17), 1767-1773, 2001
2162001
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome
M Zecca, A Prete, R Rondelli, E Lanino, A Balduzzi, C Messina, F Fagioli, ...
Blood 100 (4), 1192-1200, 2002
2102002
Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation
C Messina, F Locatelli, E Lanino, C Uderzo, G Zacchello, S Cesaro, ...
British journal of haematology 122 (1), 118-127, 2003
1882003
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party
A Bacigalupo, F Locatelli, E Lanino, J Marsh, G Socie, S Maury, A Prete, ...
Bone marrow transplantation 36 (11), 947, 2005
1872005
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment
A Del Fattore, B Peruzzi, N Rucci, I Recchia, A Cappariello, M Longo, ...
Journal of medical genetics 43 (4), 315-325, 2006
1772006
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation
E Zino, G Frumento, S Marktel, MP Sormani, F Ficara, S Di Terlizzi, ...
Blood 103 (4), 1417-1424, 2004
1672004
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a …
A Bacigalupo, E Lanino, A Prete, F Locatelli, A Locasciulli, S Cesaro, ...
Haematologica 95 (6), 976-982, 2010
1612010
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population
G Lucchini, M Introna, E Dander, A Rovelli, A Balduzzi, S Bonanomi, ...
Biology of blood and marrow transplantation 16 (9), 1293-1301, 2010
1582010
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain
GB Ferrara, A Bacigalupo, T Lamparelli, E Lanino, L Delfino, A Morabito, ...
Blood 98 (10), 3150-3155, 2001
1372001
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis
A Taranta, S Migliaccio, I Recchia, M Caniglia, M Luciani, G De Rossi, ...
The American journal of pathology 162 (1), 57-68, 2003
1142003
Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study
A Cohen, A Rovelli, DF Merlo, MT Van Lint, E Lanino, D Bresters, M Ceppi, ...
Journal of clinical Oncology 25 (17), 2449-2454, 2007
1092007
Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
C Uderzo, S Bonanomi, M Renoldi, P Ferrari, M Iacobelli, G Morreale, ...
Transplantation 82 (5), 638-644, 2006
1032006
131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients
A Garaventa, O Bellagamba, MSL Piccolo, C Milanaccio, E Lanino, ...
British journal of cancer 81 (8), 1378, 1999
1031999
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors
F Locatelli, M Zecca, C Messina, R Rondelli, E Lanino, N Sacchi, ...
Leukemia 16 (11), 2228, 2002
1012002
Mutations in OSTM1 (Grey Lethal) Define a Particularly Severe Form of Autosomal Recessive Osteopetrosis With Neural Involvement
A Pangrazio, PL Poliani, A Megarbane, G Lefranc, E Lanino, M Di Rocco, ...
Journal of Bone and Mineral Research 21 (7), 1098-1105, 2006
992006
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20